3D Global Biotech Inc.(TW:6808)
NT$26.10+0.10 (+0.38%)
TW:6808
3D Global Biotech Inc. financials statements
NT$26.10
At close:+0.10 (+0.38%)
3D Global Biotech Inc. (6808) Income Statement
3D Global Biotech Inc. Income Statement
Last quarter (Q2 2026), 3D Global Biotech Inc.'s total revenue was NT$55.30M, an increase of 26.64% from the same quarter last year. In Q2, 3D Global Biotech Inc.'s net income was NT$-11.87M. See 3D Global Biotech Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 206.74M | NT$ 265.69M | NT$ 20.63M | NT$ 13.64M | NT$ 11.07M | |
| NT$ 127.50M | NT$ 174.51M | NT$ 5.27M | NT$ 2.72M | NT$ 1.80M | |
| NT$ 86.05M | NT$ 85.81M | NT$ 68.13M | NT$ 69.00M | NT$ 64.01M | |
| Depreciation and Amortization | NT$ 27.65M | NT$ 21.84M | NT$ 22.89M | NT$ 25.86M | NT$ 24.89M |
| NT$ 69.10M | NT$ 118.02M | NT$ -35.85M | NT$ -57.02M | NT$ -35.82M | |
| NT$ 41.45M | NT$ 88.70M | NT$ -62.85M | NT$ -66.29M | NT$ -62.21M | |
| NT$ 10.85M | NT$ 7.58M | NT$ 3.94M | NT$ -16.85M | NT$ 1.24M | |
| NT$ 52.30M | NT$ 96.07M | NT$ -58.91M | NT$ -83.13M | NT$ -60.97M | |
| NT$ 66.53M | NT$ 91.70M | NT$ -57.95M | NT$ -67.09M | NT$ -59.70M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.86 | NT$ 1.33 | NT$ -1.03 | NT$ -1.22 | NT$ -1.11 |
| Diluted EPS | NT$ 0.84 | NT$ 1.30 | NT$ -1.03 | NT$ -1.22 | NT$ -1.11 |
| Weighted Average Shares Outstanding | 77.65M | 68.74M | 56.26M | 54.88M | 53.97M |
| Weighted Average Shares Outstanding (Diluted) | 79.23M | 70.79M | 56.26M | 54.88M | 53.97M |
Currency in TWD

